Jan

20

Next-Generation Sequencing vs. Microarrays

Filed Under Information, News 

from genengnews.com – by Shawn C. Baker, Ph.D, CSO BlueSEQ (www.blueseq.com)- Reprinted with permission from Genetic Engineering & Biotechnology News (GEN)

Is it time to switch?

With recent advancements and a radical decline in sequencing costs, the popularity of next generation sequencing (NGS) has skyrocketed. As costs become less prohibitive and methods become simpler and more widespread, researchers are choosing NGS over microarrays for more of their genomic applications.

Rising maturity in NGS systems and ancillary protocols such as library preparation and data analysis tools have certainly contributed to the increasing popularity among the research community. Whether it’s a need for more accurate data, better resolution, pressure from granting agencies, or just plain fear of being left behind the technology forefront, it’s clear that the demand for revolutionary sequencing technologies that deliver fast, inexpensive, and accurate genomic information has never been greater.

microarrays

As outlined in a previous article (GEN Sep 1, 2012; Vol. 32, No. 15), NGS technologies have made great strides both economically and technically, and are gaining in popularity since first appearing on the scene less than a decade ago. With the cost of sequencing a human genome soon to drop to just over $1K and a market trend towards cheaper instrumentation, NGS is more affordable than ever for projects with even the tightest of budgets.

The immense number of journal articles citing NGS technologies is sending a clear message to array users that NGS is no longer just for the early adopters. Once thought of as cost prohibitive and technically out of reach, NGS has become a mainstream option for many laboratories, allowing researchers to generate more complete and scientifically accurate data than previously possible with microarrays.

Microarrays’ Proven Track Record

With all the advancements that NGS has made, why is anyone still using microarrays? The answer is, “lots of reasons!” Microarray platforms have a proven track record spanning nearly two decades in the lab. And with practice comes mastery—researchers have grown comfortable both with operating the technology and analyzing the results. Microarrays are generally considered easier to use with less complicated and less labor-intensive sample preparation than NGS. The same goes for data analysis. While there are still many tools for data analysts to choose from, a general consensus has emerged on the major methods for processing the data. And, despite the rapid drop in the cost associated with NGS, arrays are still more economical and yield higher throughput, providing significant advantages when working with a large number of samples.

Time to Make The Switch?

So when is it time to make the switch from microarrays to NGS? What factors should be considered when deciding between these two technologies? While researchers facing such choices may feel overwhelmed, it boils down to just a few key areas, such as research goals (e.g., discovery vs. profiling), access to technology, maturity of applications, cost per sample, and desired throughput. These key aspects for the primary genomic applications are addressed separately below. For some applications, such as chromatin immunoprecipitation, the transition to NGS is nearly complete, while for others, like cytogenetics, the transition has barely begun.

ChIP
Chromatin immunoprecipitation (ChIP) experiments were among the first to be switched from arrays (ChIP-chip) to sequencing (ChIP-Seq), as the new NGS technology provides much better peak resolution. The transition was swift as this application is less demanding in terms of what is needed from the sequencing platforms—only a small number of short reads are required. The rapid drop in the cost of NGS has accelerated the transition.

Gene Expression
Researchers have been eager to use NGS for gene expression experiments as it provides a more detailed look at the transcriptome. Arrays suffer from fundamental ‘design bias’ —they only return results from those regions for which probes have been designed. Consequently, arrays are only as good as the databases from which they are designed. Conversely, the various RNA-Seq methods cover all aspects of the transcriptome without any a priori knowledge of it, allowing for the analysis of such things as novel transcripts, splice junctions and noncoding RNAs. Despite the technical advantages of RNA-Seq, microarrays remain popular for two primary reasons. One, their longtime use as a genomics tool means many researchers are very comfortable using them—sample labeling, array handling and data analysis methods are tried and true. Two, despite NGS advancements, expression arrays are still cheaper and easier when processing large numbers of samples (e.g., hundreds to thousands).

Genotyping
For genotyping studies, microarrays are still widely adopted as they are substantially less expensive than NGS and much more conducive to processing thousands of samples required for typical genome-wide associations studies (GWAS). Unlike gene expression, array-based SNP assays are much less prone to design bias. However, as microarrays are limited in the number of SNPs they can contain, they tend to focus more on relatively common variants. Some researchers feel more emphasis should be placed on SNPs with lower minor allele frequency (MAF). Although newer arrays are being designed with lower MAFs in mind, many researchers are starting to gravitate towards sequencing as it can capture both common and rare variants. However, the major stumbling block is the cost of whole genome sequencing (WGS). To lower the cost per sample and increase the throughput, many are focusing on exome sequencing. This strategy concentrates the sequencing power on just 2% of the genome (for humans and other mammals) containing the coding sequences and ignoring the remaining noncoding regions.

Methylation
The choice is more complicated with methylation projects. While NGS unquestionably provides a more complete picture of the methylome, whole genome methods are still quite expensive. To reduce costs and increase throughput, some researchers are using targeted methods, which only look at a portion of the methylome. However, microarrays remain a popular choice as their use reduces the cost and increases throughput even further. Because details of exactly how methylation impacts the genome and transcriptome are still being investigated, many researchers find a combination of both technologies best fits their needs—NGS for discovery and microarrays for rapid profiling.

applications

Diagnostics
For the diagnostics market, the transition from microarrays to sequencing has been much slower. Clinicians are a conservative group, and not so concerned with technological advancements. They are more interested in ease of use, consistent results, and regulatory approval. Microarrays tend to fit this bill, offering a stable, proven platform. Microarrays also offer simpler data analysis, as it is known ahead of time exactly what kind of data will be returned. With NGS, there’s always the possibility of revealing something new and unexpected. While that can be really useful in a research environment, clinicians generally aren’t prepared for this extra information. But the power and potential cost savings of NGS-based diagnostics is alluring, leading to their cautious adoption for certain tests such as non-invasive prenatal testing.

Cytogenetics
Perhaps the application that has made the least progress in transitioning to NGS is cytogenetics. Researchers and clinicians, who are used to using older technologies such as karyotyping, are just now starting to embrace microarrays. Companies are catering to this need by offering updated microarrays, which provide better resolution and lower costs. As with other applications, NGS has the potential to offer even higher resolution and a more comprehensive view of the genome, but it currently comes at a substantially higher price due to the greater sequencing depth required.

Conclusion

While dropping prices and maturing technology are causing NGS to make headway in becoming the technology of choice for a wide range of applications, the transition away from microarrays is a long and varied one. Different applications have different requirements, so researchers need to carefully weigh their options when making the choice to switch to a new technology or platform. Regardless of which technology they choose, genomic researchers have never had more options.

(read more…)

Incoming search terms:

  • next generation sequencing vs microarray ppt
  • next generation sequencing comparison
  • market for microarray ppt
  • next generation sequencing ppts
  • microarray vs next gen sequencing
  • ppt next generation sequencing
  • microarray technology versus next gen sequencing
  • microarray technology versus next gen sequencing ppt
  • microarray transition to rna-seq
  • microarray versus rna sequencing

Comments

One Response to “Next-Generation Sequencing vs. Microarrays”

  1. Open Science » Links da Semana on March 12th, 2013 6:59 pm

    [...] http://www.rna-seqblog.com/information/next-generation-sequencing-vs-microarrays/ [...]

Leave a Reply




  • Social Networking Pages

    Linkedin Group

  • Follow Me on Pinterest

  • RSS SEQanswers – RNA Sequencing

    • TopHat extremely low paired mapping rate. PLS HELP! May 22, 2013
      Hey guys, I have some problems with my paried-end RNA seq analysis on Galaxy. As you can see in the bam flagstat output, my tophat alignment rate is... […]
      Felix.Lee
    • Identifying small RNA sequence within whole genome sequence May 21, 2013
      Hi all, I want to know if there are any useful bioinformatic tool to find small RNA sequence within a whole bacteria genome. Thank you in... […]
      Inma
    • standard of clean data May 21, 2013
      Hi all I recently got my prokaryotes RNA-seq data report back. the standard filter steps of the raw data set by our local sequencing center is as... […]
      Pengfei Liu
    • Problem with cummeRbund diffData() May 20, 2013
      Hi all, I'm running Tophat/cufflinks/cuffdiff for differential gene expression and analysis with cummeRbund (v 2.0.0). I'm having an issue with... […]
      Enrique Zudaire
    • How to increase rowsize in heatmap? May 16, 2013
      Hi, I am a complete newbie to all things cummeRbund and am currently fighting with generating readable heatmaps. When I use ... […]
      Mags
    • novoalign mapping May 15, 2013
      Hi, I want to use novoalign to map reads - allowing up to 15 mismatches for 100 bp paired-end reads I am new to novoalign(went through the... […]
      abh

  • RSS Biostar – RNA-Seq

    • Why am I getting so many unmapped reads in STAR, classified as "too short"?
      I am currently using STAR to map several Hi-SEQ mRNA runs. I'm having trouble getting a decent amount of reads to map, but I don't really understand why. I'm hoping you can shed some light :) In the final log, only about 50% (or less) of the reads map to the reference. I'm using a GTF in addition to the genome. The unmapped bin that most […]
    • What are the best practices for SNP identification in RNA seq transcriptome data
      I have 20 RICE RNA seq tranascriptome data hiseq 2000 platform paired end reads. I aligned fasta reads with BWA and remove PCR duplicates with PICARD. Later I call SNP with samtools using various parameters. I would like to clarify what parameters should I used while alinging to reference rice genome for looking SNP location 100 bp upstream and 250 bp downst […]
    • How do TopHat options -g , --supress-hits, and Bowtie options interplay?
      Hi, I am currently using TopHat2 to map RNA-seq runs. I think there have been some changes pertaining the -g option. Does anyone know how it works now? I used to think that setting -g would look for n alignments for a given read, report them [if top-scoring] and discard those reads that had more than g [top scoring] alignments. Now, the description sounds mo […]
    • What happened to -k in TopHat for multiple-mapping reads?
      Selecting -g n in tophat does not discard reads mapping more than n, but instead only reports n alignments for those out all all their TOP scoring alignments. I think there used to be an option -k that would allow one to discard reads that topped x alignments -- whatever happened to that? I only see -g in the tophat 2 manual, no reporting options like before […]
    • Does tophat use the library-type information for mapping, or just for the XS flag?
      When I specify library-type to TopHat, i.e., first-strand, second-strand, unstranded, TopHat appends a value + or - to the XS:A flag, which is useful for subsequent analyses, such as annotation. However, does this information actually influence the "mappability" of reads, or is this unaffected? My thinking is that the information would be considere […]
    • Purpose of Y-shaped adapters in Illumina Sequencing?
      Hi all, Y adapters different sequences to be annealed to the 5' and 3' ends of each molecule in a library. The arms of the Y are unique, and the middle part, connected to the DNA fragment, is complementary. What are the advantages of this? My take of this over having fully-complementary adapters (ADAPTER1 - - - - - ADAPTER1) is that: -Upon primer a […]